For those new, the following is extremely heavy on the

New Post Public Reply Private Reply Replies (1) Message Board
petemantx
1,112
For those new, the following is extremely heavy on the sarcasm.

The last few weeks seems to have proven what so many on this board keep trying to tell us, there is absolutely no nefarious doings being played by outsiders (whether MMs, hedge funds, cabals, major trading groups, whomever)against IPIX. There are very few shorts and for certain no naked shorts (of course, if there were wouldn't the "naked" mean they couldn't be traced?). What we have is a perfectly trading market adhering to all the rules put in place by the SEC. If any of the named bodies above were fiddling with the trading, we certainly would be protected by FINRA who would throw the top management of firms doing such brazen thievery in jail (or more likely give them a a token slap on the wrist, tell them not to do it again, and let them keep about 95% or more of the money they filched from honest investors with their illegal dealings.

Now how can I support such belief in the system such that it must have been bad company news that sent the stock price dropping? See the following:

1- B found to be one of only a handful of drugs found to be lethal to CV19 via computerized model of over 11K drugs.
2- Further testing by a govt lab showed B exceptionally effective in killing CV in a petri dish.
3- Further testing showed B killed 85% of CV19 within an hour against an extremely tough strain of CV19 in human kidney tissue
4- Further testing showed B killed 97% of CV19 in human lung tissue.
5- RBL that did the lab work on the human lung tissue (and had worked with B since 2018 against antifungals was so impressed with the results that they co-authored a grant request to do a PAN-CORONA investigation of B.
6- Both RBLs plan on publishing peer review articles of the work and findings they did on B because the results were so stellar.
7- Further testing at RBL showed at the lowest dose given to date B still showed a 90% effective kill rate of CV19 whereas Remsdesivir only showed a 50% kill rate. Thus, the SI (selectivity index), which is a great aid in determining those drugs with the highest expected success rate against CV19 and the safest, should be MUCH higher for B compared to Rems....
8- Testing results listed above shows that Brilacidin should kick Rems.... ass in a head to head trial.
9- Govt has already committed to a $2B order for Rems.... product. What would they commit to a product that wipes out Rems...?
10- Grant request was submitted in early July and keeps getting closer and closer to being announced.
11- B's 3 MOAs against CV19 gives it a Billion X Billion greater chance of viruses not being able to develop a resistance to it compared to all other drugs that have only a single MOA to kill CV19.
12- B's 3-in-1 properties of being antibacterial, anti-inflammatory, antiviral, and having strong immunotherapeutic properties makes it able to attack the results of the CV19 such as lung cell death, brain swelling, kidney disruption, bowel disruption, cytokine storm, etc while most every other drug just is able to try and kill the virus to a far, far less greater effect than B.
13- B does not alter the DNA of the human genome. Most other major drugs being discussed, especially for developing a virus, affect the DNA in a recombinant or like manner and to date NO DRUG HAS EVER BEEN tested to see what the long term effects on humans is of these drugs. But then, who doesn't mind for-profit companies playing with the human genome?

I think the above has pretty much made my point. Why wouldn't all stock holders have realized the price would plummet of our shares when we have been faced with the above body of news? Who would ever have thought such mind boggling success after success for B against CV wouldn't have set BIG MEDICINE on its ear (or maybe that is one of the problems, BIG MEDICINE realizes what a threat Brilacidin brings to SO MANY of their drugs which don't cure anything, just treats conditions for life long needed therapies off of which they happen to make a fortune? Who wouldn't have expected a major drop almost daily at the last second and a major drop right out of the gate in the first 15 minutes of trading by the MMs?

Yes, I now realize I should pity all us dumb long stock holders for the rose-colored glasses we have been wearing. Even a fool could look at the data above and see we were headed in an ever increasing spiral down in share price.

And if you believe that, you are most likely profiting from this unconscionable attack on IPIX. Not blaming the traders that buy and sell daily, that is all part of the game. But the larger game is being allowed by the regulatory bodies IMO and though they know how to fix the system the big money says to keep their hands off - and so they do.

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Honeywell Aerospace Faces Securities Lawsuit Amid Turmoil

Updated Category News Views 3

Legal Storms Brewing for Honeywell Aerospace Well, stock aces, here's a curveball for anyone with a stake in Honeywell Aerospace Inc. (NASDAQ: HONA). The DJS Law Group tossed a legal grenade right into the heart of Honeywell's operations. Allegations fly that the company's been playing fast and loose with the truth during its supply chain saga. The Heart of the Allegation...

Continue Reading
Laredo Oil Eyes Big Gains in Argentina's Oil Play

Updated Category News Views 5

Argentina's Oil Play: Laredo Oil's Bold Venture Talk about shooting for the stars. Laredo Oil's second tête-à-tête with Santa Cruz Province's big wigs highlights their itch to rejuvenate Argentina's tired oil fields. For folks who know the nitty-gritty of oil, we're talking about the Golfo San Jorge Basin, a place where old dogs might learn new tricks thanks to that...

Continue Reading
Selling Montana Cabins: Tips from Shawna Norry

Updated Category News Views 4

Understanding the Challenges of Selling Montana Cabins When folks think about selling real estate, the logistics of marketing quaint Montana cabins or lifestyle properties can be different than your typical city apartment. In the wide-open spaces of places like Libby, Montana, seller needs aren't just about showing a property—it's about telling a story. Shawna Norry, an...

Continue Reading
Dairy Blends Market Eyes USD 15.38B by 2035 Growth

Updated Category News Views 3

The dairy blends market, set to barrel towards USD 15.38 billion by 2035 according to Credence Research, isn't just a numbers game. It's a tug-of-war between different fats, regions, and regulations. For those betting on future market movements, this shouldn't be a passing glance. Rising from USD 9.97 billion in 2025, these figures suggest consistent waves rather than...

Continue Reading
PAG Secures $355M to Accelerate Aggressive Growth

Updated Category News Views 9

Platform Accounting's Bold Expansion Move When you hear about a $355 million strategic financing round, it paints a picture of company ambitions colored in big, bold strokes. Platform Accounting Group (PAG) has managed to secure such a hefty financial backing from Treville Capital Group, taking a serious shot at expanding its footprint and offerings. This is no small...

Continue Reading
Jackson Hewitt Aims to Recruit 15,000 Seasonal Staff

Updated Category News Views 8

Revving Up for Tax Season: Jackson Hewitt's Hiring Push When tax season looms, the hustle can't be understated, and Jackson Hewitt is cranking it up by hunting for 15,000 new recruits to tackle this annual financial circus. Starting October 26, this hiring fest is open season across the nation, pulling out all the stops to bolster its workforce. But what does this mean...

Continue Reading
Tutoring America Champions Educational Equity with Grants

Updated Category News Views 11

Bolstering Educational Support for Low-Income Students In a world where opportunities hang on the thread of education, Tutoring America stands as a beacon for those left behind. This nonprofit tackles the education gap head-on, aiming to uplift low-income kids before they hit high school turbulence. Frankly, what they're doing is more than just good work—it's laying the...

Continue Reading
Primoris Faces Allegations Over Misleading Project Costs

Updated Category News Views 3

Primoris in the Legal Crosshairs Here's something that's bound to rile up any investor keeping tabs on NYSE: PRIM like it's their personal stock ticker. Apparently, Primoris Services Corporation has found itself neck-deep in some murky waters. This time, it's law firm Moore Law PLLC that's raising the alarm bells, calling on shareholders to step into the legal ring....

Continue Reading
Mastering Power Efficiency with Phase Converters

Updated Category News Views 9

Powering Multiple Machines: A New Approach? You ever look at a workshop crammed with machines and wonder if it's all a waste of space, time, and money? Jay Yuergens from North America Phase Converter Co. gives us the lowdown on how one rotary or digital phase converter can handle the load. And let me tell you, it ain't as crazy as it sounds. It's all about finesse and...

Continue Reading
Lincoln's Legal Tangle: Stock Plunge Sparks Lawsuit

Updated Category News Views 2

Lincoln Educational's Troubles Unravel You think you've seen it all, then boom—Lincoln Educational Services hit the skids with their stock diving close to 25% back in August 2026. This ain't your usual small hiccup; we’re talking a lawsuit filed and investors eyeing action as miserly as a broker when the market tumbles. News like this? It shakes the rafters of any...

Continue Reading

Top 5 Most Recently Viewed Articles

Transforming a Decade of Investment: The Ensign Group Journey

Updated Category News Views 176

Transforming a Decade of Investment: The Ensign Group Journey Ensign Group (NASDAQ: ENSG) has shown a remarkable performance over the last decade, surpassing the market with an impressive annualized growth rate of 12.64%. This extraordinary growth results in an average annual return of 23.92%, highlighting the potential benefits of long-term investments. Significance of a...

Continue Reading
CommunityRewards™ Partners with 305 Pink Pack for Charity Event

Updated Category News Views 338

Join CommunityRewards™ for a Unique Charity Event CommunityRewards™ is excited to announce its partnership with 305 Pink Pack for an inspiring fundraising event. Together, they will host a special night at the Miami Heat vs. Atlanta Hawks NBA game, celebrating local community efforts to support women battling cancer. This event will take place at the Kaseya Center,...

Continue Reading
Aberdeen Hikes Distribution for MMT by 22% in Bold Move

Updated Category News Views 23

In the ever-shifting dance of fund management, Aberdeen Multi-Market Income Fund is taking some bold new steps. If you're holding some shares of NYSE:MMT, you're about to see a plumped-up distribution check thanks to a hefty 22% increase in monthly payouts. But is this move pure bravado or a calculated masterstroke? Mood Shift: Managed Distribution Policy Kicks In The...

Continue Reading
Ryan Specialty Enhances Financial Position with $600 Million Notes Offering

Updated Category News Views 198

Ryan Specialty Prices $600 Million in Senior Secured Notes Ryan Specialty Holdings, Inc. (NYSE: RYAN) is making headlines with its recent announcement regarding the pricing of an impressive $600 million aggregate principal amount of senior secured notes. This comes as a significant initiative by Ryan Specialty, LLC, an indirect subsidiary of the company, aimed at...

Continue Reading
Advancing Pediatric Research: Pied Piper Foundation's Mission

Updated Category News Views 372

Pied Piper Foundation Joins CBTN Executive Council The Children's Brain Tumor Network (CBTN) is pleased to announce a new strategic partnership with the Pied Piper Foundation, which has recently joined the Executive Council. This collaboration brings together CBTN's expertise in childhood brain cancer research and the Pied Piper Foundation's strengths in fundraising and...

Continue Reading